Provided by Tiger Fintech (Singapore) Pte. Ltd.

HEC CJ PHARM

15.880
0.000
Volume:- -
Turnover:- -
Market Cap:13.97B
PE:26.47
High:15.880
Open:15.880
Low:15.880
Close:15.880
52wk High:16.064
52wk Low:7.172
Shares:879.97M
HK Float Shares:653.77M
Volume Ratio:- -
T/O Rate:- -
Dividend:1.50
Dividend Rate:9.45%
EPS(LYR):0.600
ROE:5.87%
ROA:3.32%
PB:1.50
PE(LYR):26.47
PS:3.43

Loading ...

Company Profile

Company Name:
HEC CJ PHARM
Exchange:
SEHK
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
YiChang HEC ChangJiang Pharmaceutical Co Ltd is a China-based company primarily engaged in the development, manufacturing and sale of pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic diseases. The Company's main products include Kewei (Oseltamivir Phosphate Capsules and Granules), Ertongshu (Benzbromarone Tablets), Oumeining (Telmisartan Tablets), Linluoxing (Moxifloxacin Hydrochloride Tablets) and Olmesartan Tablets and other products. The Company is also engaged in the centralized procurement business. The Company mainly conducts its business in the domestic market.